Logo image
Virtual reality distraction therapy for chronic pain management
Dissertation   Open access

Virtual reality distraction therapy for chronic pain management

Lynn Nakad
University of Iowa
Doctor of Philosophy (PhD), University of Iowa
Summer 2024
DOI: 10.25820/etd.007733
pdf
Lynn Nakad Dissertation Final789.91 kBDownloadView
Open Access Free to read and download

Abstract

Chronic pain is highly prevalent in the general population and associated with reduced quality of life, health outcomes, and increased healthcare utilization. Due to adverse effects of opioids, especially with prolonged use, current guidelines recommend nonpharmacological therapies as first-line treatment for chronic pain, especially in combination with medication. Immersive virtual reality (VR) distraction therapy is a novel nonpharmacologic therapy that has been shown to effectively provide analgesia for acute and procedural pain in a variety of patient populations and conditions. However, only preliminary research has explored the use of VR distraction for chronic pain management. The purpose of this dissertation was to explore the chronic pain experience in adults and the use of VR distraction therapy to help manage musculoskeletal and cancer-related chronic pain. A narrative review and two studies were conducted, including a mixed-methods exploratory study and an experimental study. The review characterized pain prevalence in older adults and examined the presence of multimorbidity and its relationship with and impact on chronic pain. It found that musculoskeletal pain was the most prevalent type of chronic pain and defined consequences of chronic pain and multimorbidity. The second study explored the attitudes and treatment acceptability towards the use of immersive VR distraction therapy of older adults with chronic pain. While it had high treatment acceptability, findings suggested the need to improve usability of VR and that future studies should focus on acute exacerbations of chronic pain. Therefore, the third study tested the feasibility and preliminary efficacy of an immersive VR distraction for breakthrough cancer pain (BTcP) in hospitalized patients. VR was found to be an acceptable and easy to use treatment and preliminary results demonstrated a reduction in BTcP intensity with the VR treatment compared to usual care.
Chronic Pain Oncology Virtual Reality Distraction Therapy Non-pharmacologic Intervention Older Adults

Details

Metrics

5 File views/ downloads
70 Record Views
Logo image